Cassava Sciences, Inc. (SAVA)
2.155
+0.10
(+5.12%)
USD |
NASDAQ |
Feb 13, 12:25
Cassava Sciences Free Cash Flow : -83.91M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| cbdMD, Inc. | -1.636M |
| BioMarin Pharmaceutical, Inc. | 825.79M |
| Amicus Therapeutics, Inc. | 9.691M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
| Ovid Therapeutics, Inc. | -37.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.221M |
| Cash from Investing (Quarterly) | -0.08M |
| Free Cash Flow Per Share (Quarterly) | -0.1304 |
| Free Cash Flow to Equity (Quarterly) | -6.301M |
| Free Cash Flow to Firm (Quarterly) | -6.301M |
| Free Cash Flow Yield | -80.70% |